FGF-2와 덱사메타손이 지방기질세포의 증식 및 분화에 미치는 영향
분야
의약학 > 의공학
저자
김태호 ( Tae Ho Kim ) , 이선영 ( Sun Young Lee ) , 손영숙 ( Young Sook Son ) , 김석영 ( Suk Young Kim ) , 박의균 ( Eui Kyun Park ) , 김신윤 ( Shin Yoon Kim ) , 손민정 ( Min Jung Shon )
발행기관
한국조직공학·재생의학회
간행물정보
조직공학과 재생의학 2005년, 제2권 제4호, 362~367페이지(총6페이지)
파일형식
2a800061.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    4,500원
    적립금
    135원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Adipose tissue derived stromal cells (ATSCs) have been shown to be differentiated into several types of cells including osteoblasts. In the present study we have investigated the effects of fibroblast growth factor-2 (FGF- 2) and dexamethasone (Dex) on the proliferation and osteoblastic differentiation of ATSCs. A combination of FGF- 2 and Dex compared to untreated control stimulated proliferation of ATSCs up to 45% and 25% at day 5 and 7, respectively. Compared to FGF-2 alone, FGF-2 plus Dex further augmented proliferation of ATSCs by 15% (day 5) and 5% (day 7). In response to osteogenic stimulation, ATSCs expanded with FGF-2/Dex for 7 days were able to be differentiated into osteoblasts as revealed by increased calcium precipitation, and increased expression of osteocalcin, alkaline phosphatase and Runx2. Taken together, these results demonstrate that FGF-2 in combination with Dex stimulates proliferation of ATSCs and FGF-2/Dex-expanded ATSCs maintain a potential to be differentiated into osteoblasts.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.